PharmaNL publishes Investment Agenda for Shared Development Infrastructure

News January 30, 2025

PharmaNL today publishes the Investment Agenda for the Shared Development Infrastructure program line. This document (part 3) is an integral part of the PharmaNL investment agenda as presented on August 22, 2024, focusing on the Human Capital Growth program line. The Investment Agenda serves as a roadmap for investments aimed at strengthening the Dutch pharmaceutical value chain.

Based on a gap analysis and an expert session, the Investment Agenda identifies key themes for future grant calls under the PharmaNL program. Within the Shared Development Infrastructure program line, the emphasis is on collaboration and innovation, with growth opportunities in areas such as automation of production processes, advanced therapies, imaging and screening technologies, and AI use in the pharmaceutical sector.

Subsidy Round for Shared Development Infrastructure 2025

In the open subsidy round of 2025, a total budget of approximately 24 million euros is available within this program line. This allows for funding of 5 to 10 projects, with a maximum contribution of 5 million euros per project. The subsidy round for Shared Development Infrastructure is expected to be opened by ZonMw in March 2025 [https://www.zonmw.nl/nl/programma/pharmanl]. ZonMw manages the PharmaNL subsidy program on behalf of the Ministry of Health, Welfare, and Sport (VWS).

More Information

For more details on the background, process, and prioritization within the Investment Agenda, refer to the earlier publication in August 2024. Download the full document here:  download